Skip to main content
. 2017 Dec 20;36(10):991–999. doi: 10.1200/JCO.2017.75.7310

Fig 3.

Fig 3.

Survival by DNA-repair status and treatment arm. Progression-free survival (PFS) curves are shown by treatment arm for patients with wild-type (WT)/monoallelic or biallelic DNA-damage repair defect (DRD), as determined by next-generation sequencing of tumors shown in Figure 2 of the main manuscript: (A) abiraterone/prednisone; (B) abiraterone/prednisone plus veliparib.